Background: The osteocyte is a type of cell that appears to be one of the key endocrine regulators of bone metabolism and a key responder to initiate bone formation and remodeling. Identifying the regulatory networks in osteocytes may lead to new therapies for osteoporosis and loss of bone.
Background
It is well known that bone tissue has the capacity to alter its mass and structure in response to mechanical strain. Osteocytes are terminally differentiated cells derived from osteoblasts, which first become embedded and surrounded by osteoid matrix that subsequently mineralizes [1] . They are regarded as the mechanosensory cells that respond to mechanical loading and a variety of hormones such as vitamin D and PTH, and sends signals to other bone cells to initiate bone formation and remodeling [1] . A better understanding of the gene networks regulating osteocytes can therefore Open Access lead to new therapies for osteoporosis, loss of bone in space travel and extended bed rest. However, even though osteocytes are the most abundant cells in bone, the regulatory pathways controlling osteocyte biology have not been identified.
As osteocytes are embedded within the bone matrix, with a complex network between the different stages of cells within the osteoblast-osteocyte lineage, studies of osteocytes have been hampered by their inaccessibility and by the lack of molecular and cell surface markers that could be used to isolate and characterize this cell population [2] . Dentin matrix protein (DMP-1) has been shown as a good marker for the osteocyte lineage and is specifically expressed along and in the canaliculi of osteocytes within the bone matrix, suggesting a role for DMP1 in osteocyte function. Recently, we generated a mouse model containing a DMP1 region, À7892 to +4439 bp (8 kb), driving GFP and thus directing expression to osteocytes [2] . This enables us to purify osteocytes from osteoblast cells using fluorescenceactivated cell sorting, and compare the gene expression profiles in these two types of cells directly using microarray.
In this work, we developed a systems biology approach to study osteocyte biology by integrating data from microarray experiments, functional annotations and comparative genomics. This type of approaches has been shown to greatly eliminate noises contained in individual data sources, and improve the understanding of complex biological phenomena, such as Alzheimer's disease and cancer [3, 4] . Typically, this type of approaches starts with identifying a set of differentially expressed genes, and then clusters genes according to their expression profiles or functions, followed by an analysis of cis-regulatory elements presented in the promoter sequences. Our method differs from those approaches in two important aspects. First, we only considered cis-regulatory elements that are both overrepresented and evolutionary conserved. This significantly reduced the effective lengths of promoter regions when searching for cis-regulatory elements, and therefore eliminated many spurious matches. Moreover, we developed a graph theoretical method to identify transcriptional regulatory modules (CRMs) [5, 6] , which revealed interesting combinatorial relationships between several transcription factors.
Briefly, from microarray experiments, we obtained 269 osteocyte-specific genes, many of which have functions in bone or muscle development and contractility. We then identified enriched and evolutionarily conserved cis-regulatory elements from the 5 kb upstream promoter regions of a subset of 98 bone-and muscle-related genes, and used these data to construct a transcriptional regulatory network that links TFs to their putative binding sites on these 98 genes. We further proposed a graph-partitioning algorithm to identify possible cisregulatory modules [5, 6] . Our results show that many osteocyte-specific genes, including two well-known osteocyte markers DMP1 and Sost, have highly conserved clustering of muscle-related cis-regulatory modules, thus supporting the concept that a muscle-related gene network is important in osteocyte biology and may play a role in contractility and dynamic movements of the osteocyte.
Results and discussion
Bone and muscle-related genes are over-expressed in osteocyte cells To identify potential regulatory networks of osteocytes, we obtained gene expression profiles from osteocytes purified from calvariae of 5-8 day-old mice expressing 8 kb DMP1 promoter driving GFP. As a control, we also obtained gene expression profiles from GFP-negative cells, which contain about 60% osteoblasts at different stages (before DMP1 gene turns on) and some macrophages. The microarray data is then normalized using GCRMA [7] and significantly differentially expressed genes were identified. We identified 269 genes that are over-expressed by at least 3 fold in osteocytes with a FDR-corrected p-value < 0.05 (See Methods).
Using the DAVID functional annotation tool [8] , we found that the 269 osteocyte-specific genes are significantly enriched in several GO terms, which are further grouped into several functional clusters ( Table 1) . As expected, the most significant clusters include GO terms such as "extracellular region", "ossification", "bone remodelling" and "system development". Interestingly, our results also showed that osteocytes express many genes and transcription factors (TFs) known to control muscle differentiation and contractility. For example, over 12 myosin-related genes are over-expressed in osteocytes, as well as several TFs such as myogenin, Mef2c, and Myf5.
Conserved cis-regulatory elements in osteocyte-specific genes To study the transcription regulation of the osteocytespecific genes, we combined the 98 genes in the boneand muscle-related functional clusters and analyzed the cis-regulatory elements occurring on their promoters. Using the web tool Whole Genome Vista (WGV) [9] , we searched for known TF binding motifs that are conserved between the mouse and human genomes from the 5 kb promoter sequence upstream to the transcription starting site for each gene. As expected, many motifs identified are known to be related to bone and muscle functions, including myf2, Ets family, Smad3 sites, and FoxO1/4 cis-elements. Strikingly, 67 of the 98 genes had 10 or more conserved Mef2 binding sites in their 5 kb promoter regions. Furthermore, Mef2c is also a direct target of Mef2 with over 68 conserved binding sites, suggesting that this gene regulates itself (Table 2) .
Modular structure of the transcriptional regulatory network
In order to identify possible combinatorial affects of TF binding sites, we created a transcriptional regulatory network including the 98 over-expressed genes and the known TF binding sites that are not only conserved between mouse and human, but are also determined by WGV to be enriched in some genes (i.e., their number of appearance on at least one of the 98 genes is statistically more significant than the rest of the genome). This increases the reliability of edges, while reducing the network size to a management size. A total of 153 overrepresented TF motifs were identified for the 98 gene set. We created a network of these genes and TFs, with edges between genes and TFs representing an overrepresentation of that TF's binding site on that gene. We next applied Qcut [10] , a spectral-based graph clustering algorithm for finding relatively dense subnetworks (aka communities in social sciences), to this initial regulatory network (see Methods). By optimizing a statistical score called the modularity, the Qcut function can determine by itself the most appropriate number of communities in the network. We identified 6 communities, each containing some genes that share a large set of common TF binding sites ( Fig. 1(a) ). Cluster 6 shows a strong community between 16 genes and their common TF binding sites, which is representative of many TFs coordinately regulating a small set of genes ( Fig. 1(b) ). Cluster 1 shows potential co-regulation of Mef2c, Myf5 and Irx5 by a common set of TFs (Fig. 1(c) ).
A putative model of the transcriptional network A proposed regulatory network model (Fig. 2) has been created using our network results and our prior biological knowledge. The model demonstrates the regulation of DMP1 and Sost, two genes highly expressed in osteocytes, by Mef2c and Myogenin. It is also observed that Mef2c contains a high level of Mef2c binding sites, suggesting that this gene regulates itself. These putative models can be used to generate hypotheses for experimental validation. We now have an ex vivo culture system for pure osteocytes in their proper microenvironment in which they make appropriate levels of osteocyte specific genes, and experiments from this model are currently underway.
Conclusion
In this paper, we introduced a systems biology method for identifying and analyzing transcriptional regulatory networks in the osteocyte. We integrated data from microarray experiments, functional annotations, comparative genomics, and graph-theoretic analysis to create a putative model of the transcriptional regulatory networks in osteocytes. Many parts of the network can be confirmed by the literature, and more direct experimental validations are underway. Our model shows that many osteocyte-specific genes, including two wellknown osteocyte markers DMP1 and Sost, have highly conserved clustering of muscle-related cis-regulatory modules, thus supporting the concept that a musclerelated gene network is important in osteocyte biology and may play a role in contractility and dynamic movements of the osteocyte.
Methods

Microarray experimental procedures and analysis
Three independent experiments were carried out with mice containing the DMP1-GFP transgene that marks osteocytes by the GFP expression. Following cell separation utilizing fluorescence activated cell sorting, the RNA was isolated from the GFP-positive and GFP negative cells. All experiments showed enrichment of 15 to 50 fold in DMP1 mRNA expression, a measure of osteocyte enrichment. The experiments with the 50 fold enrichment of osteocytes (GFP-positive) were focused on for this study with 3 replicate determinations of expression levels of all genes.
Microarray experiments were conducted using the Affymetrix 430A mouse chip with over 21,000 probes set. These raw .cel files are then normalized by GCRMA using Limma included in the Bioconductor package in R [7] . In these experiments we used the B statistic with B values greater than 3 and FDR = .05. We identified the top 269 genes out of the 21,000 that were differentially expressed between GFP-positive and GFP-negative cells.
Deriving the 98 gene set related to bone/muscle The top 269 differentially expressed genes were functionally clustered using the DAVID Bioinformatics tool, which also provides enrichment scores for each cluster [8]. For each GO term associated with a group of genes, a p-value is computed by the hypergeometric distribution, and then adjusted for multiple testing using the Benjamini method [8] . The enrichment score for a cluster is then calculated as the negative logarithm of the geometric mean of the individual GO p-values [8] . 98 of these 269 genes are functionally enriched in the skeletal/bone and muscle biology clusters with enrichment scores of 11.72 and 5.18, respectively.
Building the transcriptional regulatory network
The 98 gene set was input into Whole Genome Vista [9] for discovery of conserved and over-represented TF binding sites occurring on the 5 kb upstream promoter sequence upstream to the transcription starting site of a gene. The motifs found by Vista are known motifs from the TRANSFAC database [11] . The significance of a motif found on a gene is determined by a p-value based on the number of occurrences of the motif in the 5 kb upstream promoter region of this gene as compared to the total number of occurrences of the motif in the same 5 kb region of the rest of the RefSeq genes in the genome. A potential regulatory network was created from this data in which an edge between a gene and a TF represents an over-representation of that TF's binding site on the gene's promoter, as according to WGV.
Detecting network modules
In order to identify modules from the transcriptional regulatory network, we first assigned a cosine similarity score to each pair of genes according to their shared TFs. A weighted gene-gene network was then created in which an edge weight between two genes corresponds to their similarity score. This similarity matrix was then converted to a sparse network by connecting each gene to its k nearest neighbours (k = 7) with a similarity cutoff score equals 0.5. The network is then partitioned using the algorithm Qcut [10] , resulting in gene sets that have many common TF binding sites. The regulatory network was input into Cytoscape [12] for visualization, along with the gene set partition information.
